Background and Purpose-To determine how cerebral blood flow (CBF), total and microvascular cerebral blood volume (CBV), and blood oxygenation level-dependent (BOLD) contrast change during autoregulation and hypotension using hemodynamic MRI. Methods-Using arterial spin labeling and steady-state susceptibility contrast, we measured CBF and changes in both total and microvascular CBV during hemorrhagic hypotension in the rat (nϭ9). Results-We observed CBF autoregulation for mean arterial blood pressure (MABP) between 50 and 140 mm Hg, at which average CBF was 1.27Ϯ0.44 mL ⅐ g Ϫ1 ⅐ min Ϫ1 (meanϮSD). During autoregulation, total and microvascular CBV changes were small and not significantly different from CBF changes. Consistent with this, no significant BOLD changes were observed. For MABP between 10 and 40 mm Hg, total CBV in the striatum increased slightly (ϩ7Ϯ12%, PϽ0.05) whereas microvascular CBV decreased (Ϫ15Ϯ17%, PϽ0.01); on the cortical surface, total CBV increases were larger (ϩ21Ϯ18%, PϽ0.01) and microvascular CBV was unchanged (3Ϯ22%, PϾ0.05). With severe hypotension, both total and microvascular CBV decreased significantly. Over the entire range of graded global hypoperfusion, there were increases in the CBV/CBF ratio. Conclusions-Parenchymal CBV changes are smaller than those of previous reports but are consistent with the small arteriolar fraction of total blood volume. Such measurements allow a framework for understanding effective compensatory vasodilation during autoregulation and volume-flow relationships during hypoperfusion. (Stroke. 1999;30:2197-2205.)
M
any organ systems, including the brain, have the ability to autoregulate blood flow, despite large changes in systemic mean arterial blood pressure (MABP). [1] [2] [3] [4] [5] Because of technical difficulties, few autoregulation studies have additionally examined cerebral blood volume fraction (CBV) changes. 6 -8 CBV is thought to be an important determinant of intracranial pressure (ICP), as a result of the fixed volume of the cranial cavity. 9, 10 Because increased ICP has been implicated in ischemic tissue damage and risk of brain herniation, proper understanding of CBV dynamics may be important in the assessment of clinical manipulations, particularly in the setting of intracranial pathology.
To maintain CBF when MABP is decreasing, cerebrovascular resistance (CVR) must decrease, and most researchers have assumed that this vasodilation requires a large CBV increase. 7, 11, 12 However, evidence for this has been inconsisSee Editorial Comment, page 2204 tent in previous literature reports. Most previous measurements have been made on the cortical surface and used either indirect CBV markers (eg, mean transit time and separate measurement of blood flow) 7 or localized properties, such as pial vessel diameter, that may not reflect parenchymal CBV. 2, [13] [14] [15] The large CBV changes (Ͼ100%) reported by some studies appear to require active mechanisms for capillary and venous dilation to be consistent with known distributions of resistance and blood volume in arterial, capillary, and venous compartments. This may reflect the effects of measuring CBV changes on the cortical surface, known to have a greater proportion of arteries and arterioles than the parenchyma. Grubb et al 8 described a much smaller CBV increase of 18% at 35 mm Hg in brain parenchyma with X-ray fluorescence, whereas studies with a photoelectric technique reported no CBV changes during hemorrhagic hypotension. 6 Below the autoregulated range, flow becomes pressuredependent, which leads to global hypoperfusion; the behavior of CBV during hypoperfusion may be different from that during autoregulation. Global and focal models have suggested that volume-flow mismatch (ie, high or preserved CBV with low CBF) may be a feature of early ischemia 16 -19 and represent tissue at risk of infarction. 16, 20, 21 Such regions have been observed in humans and tend to progress to infarction without intervention. 20, 22 Steady-state susceptibility contrast MRI measurements of relative regional CBV provide a unique combination of high sensitivity, accuracy for measurement of CBV changes, and high temporal resolution for in vivo studies. [23] [24] [25] In addition, the technique may be sensitized to vascular size, permitting measurement of both total and microvascular blood volume. 26, 27 Continuous assessment of perfusion by tagging, including volume and water extraction (CAPTIVE) imaging, which combines susceptibility contrast with arterial spinlabeling (ASL), permits frequently repeated equilibrium measurement of both CBF and CBV. 28 The present article reports the first application of hemodynamic MRI techniques to examine volume-flow relationships during successful autoregulation and global hypoperfusion caused by hemorrhagic hypotension. We have measured CBF with ASL and compared these values with those of previously published reports. Additionally, we have measured how total and microvascular CBV changes with MABP in several brain regions. Finally, we have examined how gradient and spin echo blood oxygen level-dependent (BOLD) effects change with MABP.
Materials and Methods

Animal Preparation
All experimental protocols were approved by the Office of Laboratory Animal Research at Massachusetts General Hospital. SpragueDawley rats (321Ϯ25 g, nϭ12; Charles River Laboratories Inc, Wilmington, Mass) were mechanically ventilated, paralyzed, and anesthetized with 0.7% halothane in a 2:1 mixture of air:oxygen. Two femoral intra-arterial catheters were placed: 1 for monitoring MABP and drawing arterial blood gases and hematocrit (these were measured in more than half of the animals), the other for arterial blood withdrawal. A femoral intravenous catheter allowed administration of the contrast agent. Arterial blood withdrawal (rate, 4 to 20 mL/h) was used to reduce MABP at approximately 1 mm Hg/min. Animals were placed in a head holder (David Kopf Instruments) inside a surface radiofrequency coil with the brain 1 cm above the heart.
CAPTIVE Measurements
In a group of rats (nϭ7) imaged at 4.7 T, the contrast agent methoxypoly-(ethylene glycol)-polypropylene-dysprosium-diethylenetriaminepentaacetic acid (MPEG-PL-Dy-DTPA) (180 mol/kg) was infused immediately after the acquisition of coronal baseline images. In 3 of these rats, plasma contrast agent concentration was measured (Galbraith Laboratories) before hemorrhage and during mild and severe hypotension.
In a single slice located at bregma, ASL measurements were performed with the following parameters: conventional gradient echo, repetition time (TR)/echo time (TE), 4000/5 ms; field of view (FOV), 25 mm; slice thickness, 2 mm; imaging matrix, 32ϫ32; frequency offset, 3 kHz; gradient, 0.5 G/cm; and labeling time, 3.7 s with a 0.2-s postlabeling delay to minimize transit time effects. 29 CBF was calculated by the following:
), is the brain:blood water partition coefficient (0.88), 30 T 1b is brain T 1 (1.5 s), ␣ is the degree of labeling (0.7 before contrast and 0.6 after contrast), 28 and S label and S control are the MR signals in the presence and absence of labeling, respectively.
Multislice (8 slices, 1-mm slice thickness) gradient echo (TR/TE, 2000/25 ms) and spin echo (TR/TE, 2000/60 ms) imaging with the same in-plane resolution was performed to measure total and microvascular CBV changes, respectively. Relative CBV images were created at each MABP level by calculating changes in transverse relaxivity (⌬R2* or ⌬R2) on the basis of precontrast and postcontrast images. Fractional CBV changes were calculated as follows:
where the baseline relaxivity ⌬R2(P 0 ) is the average of measurements taken with MABP of 90 to 99 mm Hg. Using the full multislice data set, we measured CBV in 3 separate regions-ofinterest (ROIs): striatum, cortex, and cortical rim. Additionally, to facilitate direct comparison with the CBF data, we further analyzed CBV changes in the whole brain at the level of bregma. ROIs were drawn conservatively to minimize CSF and partial volume effects ( Figure 1 ). In another group of rats (nϭ2), CBV changes were imaged by used of an echo-planar sequence at 2 T, with the contrast agent monocrystalline iron oxide nanocolloid (MION) (12 mg Fe per kilogram). Imaging parameters were as follows: FOV, 25 mm; thickness, 1 mm; matrix size, 32ϫ32; gradient echo TR/TE, 5 s/25 ms; spin echo TR/TE, 5 s/60 ms.
BOLD Studies
To measure and control for BOLD, a third group of rats (nϭ3) was imaged at 4.7 T. CBF and spin and gradient echo imaging was performed using the same parameters as in the CAPTIVE studies without infusion of contrast agent.
Statistical Analysis
All measurements in individual animals were binned on the basis of 10-mm Hg subdivisions. Standard deviations were calculated from these binned measurements in different animals. For comparison, the data were broken into 3 groups on the basis of MABPs of 50 to 140 mm Hg ("autoregulation"), 10 to 40 mm Hg ("mild hypoperfusion"), and Ͻ10 mm Hg ("severe hypoperfusion"). For the autoregulation range, linear regression was performed to compare the linear slopes. To permit comparison with CBV, the CBF data were Figure 1 . Multislice MRI spin echo coronal images of rat brain, which show ROIs for hemodynamic measurements. Arrow, Coronal slice at the bregma level, at which both CBV and CBF measurements were made. Additional CBV measurements were made in striatum (yellow), cortex (green), and on the cortical rim (blue). These regions were drawn conservatively to minimize partial volume effects.
converted to percentage change on the basis of the baseline (90-to 99-mm Hg) level. Differences between parameters during autoregulation and hypoperfusion were compared with the use of Student's 2-tailed t test using the Bonferroni correction for multiple comparisons.
Results
The physiological parameters of the animals are presented in Table 1 ; only hematocrit changed significantly, decreasing from 38Ϯ3% before hemorrhage to 29Ϯ4% measured during both mild and severe hypotension. An 11% to 18% decrease in plasma contrast agent concentration was measured, which was not significantly different from the initial level.
Because we detected no significant differences in CBF measured with and without the contrast agent MPEG-PL-Dy-DTPA, the CBF data ( Figure 2 ) represent averages from 9 rats at 4.7 T (in 1 rat, CBF could not be measured for technical reasons). For the autoregulated range, CBF reactivity was 0.004Ϯ0.001 (mL ⅐ g Ϫ1 ⅐ min
Ϫ1
)/mm Hg, which rose to 0.0235Ϯ0.003 (mL ⅐ g Ϫ1 ⅐ min
)/mm Hg for MABP below 50 mm Hg. Between 50 and 140 mm Hg, whole-brain CBF in the slice at bregma was 1.27Ϯ0.44 mL ⅐ g Ϫ1 ⅐ min Ϫ1 (59 measurements in 9 rats).
Because we detected no significant differences between CBV changes in rats studied with MION and MPEG-PL-Dy-DTPA, the results for total and microvascular CBV ( Figure 3 ) were averaged across 9 rats (nϭ2 at 2 T and nϭ7 at 4.7 T). CBV changes in striatum, cortex, and bregma slice were similar. Regression analysis of total and microvascular CBV in the entire slice at the bregma over the autoregulated range (50 to 140 mm Hg) showed small but significant positive slopes that were not significantly different from the CBF slope or from each other ( Table 2 ). Despite Ͼ2-fold reduction in MABP, no increases in either microvascular or total CBV from baseline were observed in brain parenchyma during CBF autoregulation.
The Grubb relationship (V/V 0 ϭ(F/F 0 ) 0.38 ), 31 shown as the dashed lines in Figure 3 , accurately predicted total and microvascular CBV over the autoregulated CBF range. During hypoperfusion, it continued to fit microvascular CBV but underestimated total CBV. Between 10 and 40 mm Hg, small total CBV increases (Ϸ10%) were seen in striatum, cortex, and the whole-brain slice at bregma, whereas microvascular CBV decreased in these regions (Table 3) . On the cortical rim, total CBV increases were greater (ϩ21Ϯ18%, PϽ0.01), whereas microvascular CBV did not change significantly from baseline (ϩ3Ϯ22%, PϾ0.05). For all regions, the change in total CBV was consistently greater than the change in microvascular CBV during mild hypoperfusion, and all CBV changes were smaller than CBF decreases (Ϫ47Ϯ25%, 0.67Ϯ0.42 mL ⅐ g Ϫ1 ⅐ min
). With severe hypotension (Ͻ10 mm Hg), total and microvascular CBV fell significantly in all regions, and larger decreases were seen in microvascular than in total CBV (Table 3 ).
An example in 1 animal of volume-flow mismatch is shown in Figure 4 . A large (Ͼ50%) CBF decrease between the autoregulation and hypoperfusion range was evident. Total and microvascular CBV changes were much smaller and not immediately evident. In the parenchyma, there was a small increase in total CBV but a small decrease in microvascular CBV. On the cortical surface, total CBV was noticeably increased.
Results from the BOLD experiments are shown in Figure  5 . Although there was a trend toward increased relaxivity during mild hypoperfusion for both gradient and spin echo BOLD, these changes were not statistically significant (PϾ0.05). Maximum spin and gradient echo transverse relaxivity increases (⌬R2 and ⌬R2*) were ϩ1.0Ϯ0. 8 36 -38 Below about 50 mm Hg, CBF became highly dependent on MABP, and this lower limit compares well with previous rodent studies. 39 -41 These measurements demonstrate that ASL is consistent with more invasive flow methods and confirmed that autoregulation was present in our animal model.
Cerebral Blood Volume
CBV can be determined by both dynamic and steady-state susceptibility contrast MRI. 42, 43 This method cannot measure absolute CBV, but it does permit quantitative evaluation of CBV changes. 24, 25 During CBF autoregulation, we observed the same behavior for both total and microvascular CBV, a positive linear correlation with a slope not significantly different from that for CBF ( Figure 3 , increases in CBV on the cortical surface during hemorrhagic hypotension in dogs. These large CBV increases may be specific to the cortical surface, which is known to have a greater proportion of arterial and arteriolar CBV. Also, CBV determined indirectly from transit time and separate autoradiographic CBF measurements during low flow conditions may be inaccurate. 44 -46 In the present study, CBV measurements were made in both the deeper structures and on the cortical rim and showed that total CBV increases near the cortical surface were greater than those within the parenchyma (Table 3 , Figure 3 ). The total CBV increase of 21Ϯ18% on the cortical rim is still smaller than those of these previous measurements and could possibly reflect the effects of partial volume averaging. Several earlier studies suggest that parenchymal CBV changes are significantly smaller than those on the cortical surface. 6, 8 Grubb et al 8 used X-ray fluorescence to measure CBV changes in monkey frontal cortex. They reported that CBV increased linearly by 18% as MABP declined to 35 mm Hg. However, for CBV values obtained between 50 and 140 mm Hg, those data showed no significant CBV changes (PϾ0.10). Tomita et al 6 described a method consisting of a subcortical lamp that transilluminated 4 mm of cortex in the cat, which allowed measurement of CBV in tissue consisting of both parenchyma and cortical surface and found that CBV was constant during autoregulation.
Our observation that CBV does not increase during autoregulation appears counterintuitive, because some vessels must vasodilate to decrease CVR. This observation is consistent, however, with flow control by arterioles, which represent only a small fraction of overall CBV. By observing tissue-indicator dilution curves, Tomita et al 47 estimated the entire arterial fraction of brain CBV to be about 15%. Arterioles (15 to 100 m), a subset of this small arterial CBV, are estimated to represent Ͻ3% to 5% of total CBV. 48 Therefore, even doubling arteriolar volume without changes in other compartments would cause only a 3% to 7% rise in total CBV and a smaller effect on microvascular CBV. Accordingly, we modeled the cerebral circulation using active arteriolar resistance elements with zero compliance that are placed proximal to passive capillary and venous compartments with constant resistance and compliance, following conventional windkessel theory. 49 In this model, which is a simplification of that proposed by Mandeville et al, 50 CBV in capillaries and veins increases only if the pressure difference across them increases. Arterioles act as flow regulators and adjust resistance to maintain flow, consistent with compelling evidence that smooth muscle-laden arterioles and precapillary sphincters regulate CBF. 51, 52 The ability of arterioles to maintain nearly constant postarteriolar pressure with small volume changes is efficient and especially adaptive in the brain, in which volume changes must be tightly regulated because of the rigid cranium. 9, 52 In a more complete formulation of this model, 50 postarteriole resistance must increase as blood volume decreases. This leads to a nonlinear relationship between CBF and CBV in which CBV changes are always smaller. The relationship can be formulated as a power law that depends on the exact assumptions of the model; a reasonable estimate was empirically determined by Grubb 31 during hypercapnia: V/V 0 ϭ (F/F 0 ) 0.38 . The dashed lines in Figure 3 show the expected CBV given by the Grubb formula on the basis of the CBF changes. On the autoregulatory plateau, the Grubb formula appeared valid, in which small CBF decreases were mirrored by even smaller CBV changes. During hypoperfusion, the Grubb relationship was consistent with microvascular CBV changes but significantly underestimated total CBV. The model assumes passive postarteriolar reactivity and neglects CBV contributions from large arteries and veins. Thus, it is not surprising that the model more accurately describes microvascular CBV, which is highly weighted by capillaries, instead of total CBV, which is sensitive to the vasodilation of large arteries and veins.
Like any other method based on an intravascular tracer, the method used in this study assumed constant contrast agent levels. The removal of whole blood and the hemodilution response evoked in the animal could lead to a decrease in plasma contrast agent concentration with time. Because these measurements suggest that CBV does not increase as much as some previous reports suggest, it was important to quantify this potential error. The systemic hematocrit decrease during the experiment was 9%, leading to a contrast agent dilution of 30% to 40%, given the assumption that extravascular tissue water was solely responsible for the hematocrit changes. Because of this large potential error source, we directly measured contrast agent concentration in a subset of animals and found a far smaller decrease (11% to 18%), which was not statistically significant. Although we cannot rule out that these reported CBV changes may be underestimated by 11% to 18% and that small CBV increases could be present during autoregulation, these data argue against large (Ͼ100%) parenchymal CBV increases.
Graded Global Hypoperfusion
Once the capacity for autoregulation was exceeded, postarteriolar pressure was no longer maintained, CBF decreased, and extra-arteriolar vasodilatory mechanisms appeared to become active (we observed a small total CBV increase and the uncoupling of total and microvascular CBV from flow). The behavior of CBV within this MABP range, at which mild hypoperfusion gives way to frank ischemia, may illuminate pathophysiological events that occur during carotid occlusive disease and stroke.
Positron emission tomographic studies in humans and primates during the initial 48 hours of stroke have documented relatively mild total CBV changes from Ϫ25% to ϩ25%. 21,53-57 Positron emission tomographic and singlephoton emission computed tomographic studies in humans with carotid occlusive disease have indicated 20% to 50% CBV increases, but 20% CBV decreases have been reported in subarachnoid hemorrhage. 12,58 Tomita et al 16 observed both CBV increases and decreases during the first hour of MCA occlusion in cats. Other experiments suggest that CBV may decrease over time during prolonged ischemia. 18, 19, 28 CBV-CBF mismatches have also been noted during early ischemic stroke 18 -21,59 and during chronic carotid occlusive disease. 12, 20, 22, 60 The central volume principle states that the total CBV/CBF ratio is equal to the mean transit time 61 ; therefore, CBV increases extend the time available for nutrient exchange. Accordingly, preserved CBV with low CBF may be an appropriate response to low perfusion pressure that would enhance the potential for oxygen extraction. 11, 20 During hypoperfusion, we observed a small increase in total CBV, which supports previous evidence that flow decreases before maximal vasodilation is achieved. 11 Because flow decreased with MABP in this range, volume-flow mismatch (preserved volume in the setting of low flow) was an essential feature of early global hypoperfusion. Gibbs et al 21 have suggested that the CBF/CBV ratio (the inverse of the classic mean transit time) is a marker of perfusion pressure. In contrast, our data suggest that the CBF/total CBV ratio and the CBF/microvascular CBV ratio do not change significantly over the autoregulatory range. However, if perfusion pressure is taken to signify capillary perfusion pressure, our results are concordant, because we hypothesize that both the postarteriolar pressure and the CBF/CBV ratio are held constant during autoregulation. Once CBF decreased, both the CBF/total CBV and the CBF/microvascular CBV ratios were highly correlated with MABP, but this was due to a large CBF decrease coupled with smaller CBV changes. The possibility that chronic changes in the CBF/ CBV ratio occur in the setting of preserved flow could not be tested directly by this study.
Microvascular Versus Total CBV Changes During Hypoperfusion
According to nuclear magnetic resonance theory, gradient echo measurements reflect total CBV, whereas spin echo images are primarily sensitive to microvascular CBV. 23, 26, 27, 62 Østergaard et al, 63 by applying a quantitative approach to dynamic spin echo MRI, demonstrated that spin echo CBV measurements reflect a relative volume that is 40% of total CBV measured by positron emission tomography, consistent with estimates of small-vessel volume fraction in the brain. 64 CBV maps made with spin and gradient echo sequences have reported differences between the vascular structure in normal brain and in tumors, in which large disorganized vessels result from angiogenesis. 65 We ascribe differences between total and microvascular CBV during hypoperfusion to large-vessel vasodilation once the autoregulatory capacity of arterioles is exhausted, given that the Grubb formula appears to predict microvascular CBV but not total CBV changes (see dashed lines in Figure 3 ). One limitation of the MRI technique is that it cannot distinguish arteries from veins, both of which are capable of active vasodilation. 14, 15, 66 Because veins make up a greater fraction of baseline total CBV, the total CBV changes we observed were likely to have been due to venous vasodilation. If so, this behavior is consistent with the low-pressure hyperemia state identified by Tomita et al. 16 Microvascular CBV may be particularly sensitive to changes that occur in the capillary bed during ischemia. We observed differences between microvascular and total CBV in the parenchyma only during hypoperfusion (PϽ0.01, Table 3 ). Theoretically, Ͼ95% of the microvascular CBV signal arises from vessels with sizes between 4 and 30 m. 62 Because this largely comprises the capillary bed, which has no smooth muscle and faces a progressive decrease in perfusion pressure, it is not surprising that vasodilation is absent. Decreases in the diameters of distal cortical vessels have been noted during reduction of MABP. 67 Microvascular CBV may thus be a more direct indicator of capillary perfusion and tissue viability than total CBV, which includes both arterial and venous effects.
BOLD Changes
Because deoxyhemoglobin is paramagnetic 68 and acts as a weak contrast agent, changes in deoxyhemoglobin content affect transverse relaxivity rates and thus form the basis of BOLD contrast. 69, 70 Therefore, we examined the possibility that our CBV measurements, also based on transverse relaxivity changes, might be affected by BOLD. Such transverse relaxivity changes were found to be roughly an order of magnitude smaller than those observed during the measurement of CBV with exogenous contrast agents. Because BOLD consists of intravascular and extravascular components, the contrast agent is likely to further mitigate possible BOLD errors in the CBV measurement by eliminating the intravascular contribution. Small BOLD effects during autoregulation are consistent with the findings of small CBF and total CBV changes, given constant oxygen consumption.
Particularly significant for functional MRI studies is that our data showed only minor changes in CBV or BOLD signal during a factor-of-2 reduction in MABP from 140 to 70 mm Hg. Functional MRI is now being applied to stimuli that alter blood pressure, such as pharmacological challenges using BOLD [71] [72] [73] and CBV. 24 In these studies, BOLD and CBV changes were found to be temporally not correlated with MABP. The data presented in this study strengthen the hypothesis that these hemodynamic markers can be used to infer neuronal activity even in the presence of systemic blood pressure changes.
Conclusions
Measurement of CBF, total CBV, and microvascular CBV changes with MRI during autoregulation and graded global hypoperfusion in the same animal is a powerful method for the study of cerebral hemodynamics. These measurements support the extant literature on CBF autoregulation but challenge existing notions of CBV reactivity. As a result of possible decreases in the plasma contrast agent concentration, we could not rule out small CBV increases of 10% to 20%; however, our results support the concept that CBV changes during hemorrhagic hypotension are far less than the 75% to 250% changes reported by some previous studies. Intriguing differences between total and microvascular CBV that impli-cated large-vessel vasodilation were seen during graded global hypoperfusion. CBV-CBF mismatch was an essential component of early global hypoperfusion. Such observations support incidental observations during acute ischemia and may have significant implications for understanding the temporal evolution and underlying relevance of tissue hemodynamic measurements during stroke.
Editorial Comment
The accompanying article investigates the cerebrovascular effects of hypotension using magnetic resonance imagingbased techniques to measure CBF and CBV in anesthetized rats. CBV was measured after intravenous injection of a long-lasting contrast agent. Using gradient and spin-echo imaging, the authors were able to discriminate between total and microvascular CBV. As anticipated, CBF changed little with hypotension up to arterial pressure (AP) of Ϸ60 mm Hg, reflecting the presence of cerebrovascular autoregulation. Below 60 mm Hg, CBF decreased passively with the reduction in AP, which suggests that the autoregulatory capacity of the cerebrovascular bed was exceeded. Unlike CBF, total CBV increased when AP was reduced in the autoregulated range, whereas microvascular CBV did not change. Assuming that changes in CBV reflect corresponding changes in vascular diameter, these observations suggest that cerebral autoregulatory adjustments during hypotension occur predominantly in larger vessels, presumably, on the arterial side of the vascular tree. These important, albeit indirect, observations provide additional evidence that pial arterioles play a critical role in CBF regulation. Furthermore, they underscore the power of MRI-based techniques to monitor, in a virtually noninvasive manner, the intimate hemodynamic changes occurring in the cerebral circulation.
Also of interest is the observation that the BOLD signal did not change during hypotension, despite changes in CBF and CBV. The BOLD contrast is thought to reflect a decrease in deoxyhemoglobin that occurs in cerebral blood vessels when cerebral perfusion increases, and is related to several parameters, including oxygen consumption, blood volume, blood flow, and arterial hematocrit. 1 BOLD changes are commonly used to map brain function with MRI. 2 The findings of the present study have two important implications for studies using BOLD. First, they stress that BOLD changes cannot be assumed to reflect accurately CBF changes in all physiological conditions. This applies especially to situations in which CBV changes concomitantly with CBF. Therefore, caution should be exerted when BOLD is used as an index of CBF. Second, because changes in AP do not influence the BOLD signal, it is possible that BOLD could be used to accurately monitor brain function, even in experimental settings in which AP changes. However, in view of the change in hematocrit observed here during hypotension, this latter possibility needs to be tested experimentally.
The present study was performed with halothane anesthesia. Halothane, at certain concentrations, produces vasodilation and alters cerebrovascular autoregulation. 3 However, in this study autoregulation was preserved, which suggests that the concentration of halothane used was not sufficient to produce major cerebrovascular effects. Nevertheless, it would be desirable to test the effect of other anesthetics on segmental CBV during hypotension. Furthermore, it would be of interest to investigate the upper limit of autoregulation in order to determine whether the hemodynamic changes associated with hypertension follow a similar model. Studies addressing these issues would be an important extension of the excellent work described in this article.
